| scholarly article | Q13442814 |
| P2093 | author name string | Wu CW | |
| Whang-Peng J | |||
| Lo SS | |||
| Hsieh MC | |||
| Hsiung CA | |||
| Shia LT | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 283-287 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | British Journal of Surgery | Q4970212 |
| P1476 | title | Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer | |
| P478 | volume | 91 |
| Q95360533 | Q95360533 |
| Q95360694 | Q95360694 |
| Q34538055 | "Fast track" rehabilitation after gastric cancer resection: experience with 80 consecutive cases |
| Q55645958 | A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. |
| Q34634079 | A meta-analysis of D1 versus D2 lymph node dissection. |
| Q37931733 | A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer |
| Q34326579 | Adjuvant therapy for gastric cancer: current and future directions |
| Q26774528 | Advanced gastric cancer: What we know and what we still have to learn |
| Q64962997 | Advanced gastric cancer: the value of surgery. |
| Q36798382 | Advances in the treatment of patients with gastric adenocarcinoma. |
| Q63367375 | Cancérologie digestive : pratiques chirurgicales |
| Q37697557 | Clinical significance of lymph node metastasis in gastric cancer |
| Q26766698 | Clinical significance of lymphadenectomy in patients with gastric cancer |
| Q44404665 | Complications following D3 gastrectomy: post hoc analysis of a randomized trial |
| Q35942251 | Current management of gastric cancer |
| Q83017427 | D3 or not D3... that is not the question |
| Q47428511 | Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system |
| Q57790897 | Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications |
| Q40614622 | Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy. |
| Q43815683 | Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis |
| Q24187911 | Extent of lymph node dissection for adenocarcinoma of the stomach |
| Q37697546 | Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer |
| Q55357371 | Favoring D2-Lymphadenectomy in Gastric Cancer. |
| Q50416851 | Gastric Cancer Surgery: East and West |
| Q26766091 | Gastric cancer: Current status of lymph node dissection |
| Q89953715 | Historical assumptions of lymphadenectomy |
| Q37035123 | How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience. |
| Q60922826 | How many lymph nodes are enough?-defining the extent of lymph node dissection in stage I-III gastric cancer using the National Cancer Database |
| Q37333838 | Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials |
| Q91878220 | Impacts of the surgical safety checklist on postoperative clinical outcomes in gastrointestinal tumor patients: A single-center cohort study |
| Q85084688 | Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat |
| Q38493106 | Lymph node dissection for gastric cancer: a critical review. |
| Q40584507 | Lymph node dissection in curative gastrectomy for advanced gastric cancer |
| Q37785829 | Lymph node dissection in the resection of gastric cancer: Review of existing evidence |
| Q83915546 | Lymphadenectomy in cancer: time for a paradigm shift? |
| Q89953722 | Management of postoperative complications of lymphadenectomy |
| Q92972956 | Multimodality management of locally advanced gastric cancer-the timing and extent of surgery |
| Q40675084 | Multivariate logistic regression analysis of postoperative complications and risk model establishment of gastrectomy for gastric cancer: A single-center cohort report |
| Q83017438 | Nodal dissection for patients with gastric cancer: a randomised controlled trial |
| Q36491325 | Nomogram Estimating the Probability of Intraabdominal Abscesses after Gastrectomy in Patients with Gastric Cancer |
| Q26744183 | On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer |
| Q41452357 | Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer |
| Q44286706 | Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy |
| Q36303933 | Perspectives in the treatment of gastric cancer. |
| Q43461521 | Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients |
| Q34255463 | Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer |
| Q38051100 | Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. |
| Q36608800 | Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial |
| Q42732352 | R0 resection in the treatment of gastric cancer: room for improvement. |
| Q44551895 | Race and correlations between lymph node number and survival for patients with gastric cancer |
| Q47633003 | Race and ethnicity correlate with survival in patients with gastric adenocarcinoma |
| Q81234925 | Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer |
| Q34405857 | Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis |
| Q81564227 | Reduction of hospital stay and cost after the implementation of a clinical pathway for radical gastrectomy for gastric cancer |
| Q58605480 | Reporting of outcomes in gastric cancer surgery trials: a systematic review |
| Q51982888 | Results of specialization in the surgical treatment of gastric cancer in Peru. |
| Q36500558 | Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer |
| Q38016802 | Surgical approaches to gastric cancer |
| Q34962070 | Surgical management of gastric cancer: the East vs. West perspective |
| Q46106512 | Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis |
| Q34660654 | Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer |
| Q37803170 | The extent of lymph node dissection for gastric cancer: A critical appraisal |
| Q33608236 | The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer. |
| Q26778029 | Towards curative therapy in gastric cancer: Faraway, so close! |
| Q81730569 | [Perioperative care in digestive surgery] |
Search more.